Your browser doesn't support javascript.
loading
Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis.
Xiao, Wenjing; Guo, Jian-Ping; Li, Chun; Ye, Hua; Wei, Wei; Zou, Yaohong; Dai, Lie; Li, Zhijun; Zhang, Miaojia; Li, Xiangpei; Cai, Xiaoyan; Zhao, Jianhong; Wang, Youlian; Tao, Yi; Liu, Dongzhou; Li, Yasong; Wu, Min; Sun, Erwei; Wu, Lijun; Luo, Li; Mu, Rong; Li, Zhanguo.
Afiliação
  • Xiao W; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
  • Guo JP; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
  • Li C; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
  • Ye H; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
  • Wei W; Department of Rheumatology & Immunology, Tianjin Medical University General Hospital, Tianjin, PR China.
  • Zou Y; Department of Rheumatology & Immunology, Wuxi People's Hospital, Wuxi, Jiangsu, PR China.
  • Dai L; Department of Rheumatology & Immunology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China.
  • Li Z; Department of Rheumatology & Immunology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, PR China.
  • Zhang M; Department of Rheumatology & Immunology, The First Affiliated Hospital with Nanjing, Nanjing, Jiangsu, PR China.
  • Li X; Department of Rheumatology & Immunology, Anhui Provincial Hospital, Hefei, Anhui, PR China.
  • Cai X; Department of Rheumatology & Immunology, Guangzhou First People's Hospital, Guangzhou, Guangdong, PR China.
  • Zhao J; Department of Rheumatology & Immunology, Jining No.1 People's Hospital, Jining, Shandong, PR China.
  • Wang Y; Department of Rheumatology & Immunology, Jiangxi Provincial People's Hospital, Xinyu, Jiangxi, PR China.
  • Tao Y; Department of Rheumatology & Immunology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Liu D; Department of Rheumatology & Immunology, Shenzhen People's Hospital, Shenzhen, Guangzhou, PR China.
  • Li Y; Department of Rheumatology & Immunology, Zhejiang Provincial People's Hospital, Huzhou, Zhejiang, PR China.
  • Wu M; Department of Rheumatology & Immunology, The First People's Hospital of Changzhou, Changzhou, Jiangsu, PR China.
  • Sun E; Department of Rheumatology & Immunology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, PR China.
  • Wu L; Department of Rheumatology & Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region, PR China.
  • Luo L; Department of Rheumatology & Immunology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, PR China.
  • Mu R; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
  • Li Z; Department of Rheumatology & Immunology, People's Hospital, Peking University, Beijing, PR China.
Pharmacogenomics ; 19(5): 383-392, 2018 04.
Article em En | MEDLINE | ID: mdl-29517409

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfonamidas / Cromonas / Antirreumáticos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfonamidas / Cromonas / Antirreumáticos Idioma: En Ano de publicação: 2018 Tipo de documento: Article